What Laboratoires Bailleul does

Laboratoires Bailleul is a privately held, 100% family-owned pharmaceutical and dermo-cosmetic company headquartered in Geneva, Switzerland, with a dermatology-focused operating history of more than 75 years. The company distributes prescription medicines, OTC drugs, medical devices, dermo-cosmetics, and food supplements through pharmacy and drugstore channels, its own e-commerce storefront, and pharmaceutical licensing partners, operating in 56 countries supported by 16 subsidiaries and a workforce of 101-250 employees.

The product portfolio is anchored by four consumer sub-brands — CYSTIPHANE (hair and nail care, including anti-hair-loss shampoo and lotion plus cystine-based dietary supplements), APAISAC (sensitive and redness-prone skin), MYCOGEL (hygiene for mycosis-prone skin), and FEMILYANE (women's intimate health, including the Harmolya probiotic) — complemented by supporting lines such as Ecophane and Sebophane, and a prescription/OTC portfolio built around the 2017 Galderma asset acquisition (Efficort, Suniderma, Ionil T, Tineafin, Imacort, Imazol, Imaduo, Flucazol, Itrazol, Valaciclovir Therica). Core technology centers on cystine-based formulations for keratin synthesis and hair health, with proprietary innovation including French patent FR 2 903 309 B1 covering an anti-hair-loss active complex based on Acetyl Cysteine, Arginine, Vitis Vinifera extract, and Piroctone Olamine.

Revenue mechanics are diversified across one-time product sales (OTC, dermo-cosmetic, supplements) via retail and e-commerce, and licensing/royalty income from pharmaceutical development and commercialization partners; the company holds 250+ marketing authorizations worldwide, of which 100+ were integrated from the Galderma acquisition. There are no disclosed pricing models, no public revenue figures, no external investors, and no documented AI/ML capabilities or APIs. The business is led by a legal representative identified as Mr COUPE and operates without a publicly disclosed full management team, consistent with its private, family-controlled status.

Name

Laboratoires Bailleul

Legal name

SA Laboratoires Bailleul International

Website

https://bailleul.com

Company type

Private

Founded year

1949

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Dermo-cosmetic and dermatological pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Dermatology Specialty Pharmaceuticals (HLAIACAL)

akta.pro secondary industries

Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF)

Keywords

• Dermo-cosmetic products
• Dermatology pharmaceuticals
• Hair loss treatments
• Sensitive skin care
• Prescription dermatology

Headquarters

HQ city

Geneva

HQ country

Switzerland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Dermo-cosmetic Products: Consumer-facing dermo-cosmetic products sold through pharmacies and online for skin, hair, and nail care including CYSTIPHANE, APAISAC, and Ecophane brands.
2. Over-the-Counter (OTC) Medicines: OTC dermatological products sold without prescription including treatments for dandruff, mycosis, and skin conditions.
3. Prescription Medicines: Prescription pharmaceutical products including Efficort, Suniderma, Ionil T, Tineafin, Imacort, Imazol, Imaduo, Flucazol, Itrazol, Valaciclovir Therica, integrated through asset acquisitions.
4. Licensing and Development Partnerships: Revenue from partnering with companies on final stages of development and commercialization of pharmaceutical products, including prescription drugs, OTC drugs, and medical devices.
5. Food Supplements: Nutritional supplements for hair, skin, and nail health including Ecophane tablets and powder, CYSTIPHANE fort and anagen supplements.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Laboratoires Bailleul is a family-owned pharmaceutical company that develops, manufactures, and distributes dermatological products including prescription medicines, over-the-counter (OTC) drugs, medical devices, dermo-cosmetics, and food supplements. Its portfolio targets four therapeutic areas: hair and nails, skin conditions (acne, psoriasis, rosacea, sensitive skin), women's intimate health, and general dermatology, organized under sub-brands such as CYSTIPHANE, FEMILYANE, MYCOGEL, and APAISAC.

Product overview

Laboratoires Bailleul is a family-owned pharmaceutical company (100% family business, 75+ years in dermatology) operating in 56 countries with 16 subsidiaries. The product portfolio spans four therapeutic areas: Hair & Nails (hair loss, dandruff, nail care), Skin (dry/irritated skin, redness, acne, sensitive skin), Women's Health (intimate hygiene, menopause, maternity), and Medicines (prescription and OTC dermatology products). The portfolio is organized under four main sub-brands: CYSTIPHANE (hair loss and dandruff), FEMILYANE (women's health), MYCOGEL (mycosis-prone skin hygiene), and APAISAC (sensitive skin care). Supporting products include Ecophane supplements and shampoos, Sebophane sebum-regulating shampoo, and Harmolya probiotic supplements. The company acquired assets from Galderma in 2017 including Efficort, Suniderma, Ionil T, Tineafin, Imacort, Imazol, Imaduo, Flucazol, and Itrazol.

Differentiator

Problem solved

Functional benefit

Products and services

• CYSTIPHANE Hair care brand addressing hair loss, dandruff, and fragility, including dietary supplements (Fort, Anagen), anti-hair loss shampoo and lotion, and anti-dandruff shampoos, for men and women experiencing temporary or chronic hair loss, dandruff, or fragile hair.
• FEMILYANE Women's health brand focused on intimate hygiene, vaginal flora balance, and feminine wellness products for women managing intimate discomfort, vaginal flora imbalance, or seeking daily intimate care.
• MYCOGEL Hygiene brand for skin prone to mycosis, featuring a cleansing gel with ciclopirox olamine for body, face, and intimate areas, for consumers prone to fungal skin conditions.
• APAISAC Dermatological skincare brand for sensitive skin, including Anti-Redness Soothing Cream, Mattifying Cream, Purifying Cream, Intensive Moisturising Cream, and Lip Balm, for consumers with sensitive, redness-prone, acne-prone, or dry skin.
• Ecophane Fortifying Shampoo Shampoo for damaged and fragile hair that restores strength and volume, improving root condition and hair quality; dermatologically and ophthalmologically tested, for consumers with fragile, damaged, or weakened hair.
• Ecophane Ultra Soft Shampoo Gentle shampoo for all scalp types that restores shine, suppleness, and softness while facilitating detangling; suitable for sensitive scalps and family use from age 3, for consumers seeking daily mild scalp care.
• Ecophane Food Supplement Tablets Oral supplement for light to moderate hair and nail fragility, containing wheat and sesame protein hydrolysates with L-cystine and methionine, for consumers with mild hair and nail fragility.
• Ecophane Food Supplement Powder Powder supplement for moderate to severe hair and nail fragility and occasional hair loss, containing wheat protein hydrolysate with L-cystine, zinc, and B vitamins, for consumers with more pronounced hair and nail fragility.
• Sebophane Sebo-regulating Shampoo Mild sebum-regulating shampoo for oily, heavy, dull hair that regulates sebaceous secretions and maintains scalp flora balance using zinc PCA and copper PCA, for consumers with oily scalp and seborrheic conditions.
• Cystiphane Dietary Supplement Fort High-concentration dietary supplement with 2000mg L-cystine, Vitamin B6, Arginine, and Zinc for hair and nail strength and vitality, for consumers experiencing hair weakening and nail fragility.
• Cystiphane Anti Hair Loss Shampoo Shampoo for temporary or chronic hair loss that redensifies hair, protects from breaking, and improves hair anchorage for volume, strength, shine, and softness, for men and women experiencing hair thinning.
• Cystiphane Anti Hair Loss Lotion Topical lotion with patented anti-hair loss complex (French patent FR 2 903 309 B1) that slows hair loss and stimulates growth of existing hair; clinically proven efficacy, for men and women with androgenetic, reactive, or chronic hair loss.
• Cystiphane Dietary Supplement Anagen Dietary supplement for chronic hair loss situations related to heredity or age, containing cystine, rocket extract, milk thistle, Vitamin B6, zinc, selenium, and biotin, for consumers with chronic hereditary or age-related hair loss.
• Mycogel Cleansing Gel Hygiene gel with ciclopirox olamine for skin prone to mycosis, double dermatologically and gynecologically tested for body, face, and intimate areas, for consumers prone to fungal skin conditions and intimate mycosis.
• Harmolya Food Supplement with Lactobacillus Strains Women's health supplement containing 4 strains of live lactic acid bacteria (Lactobacillus acidophilus, L. casei, L. gasseri, L. rhamnosus) with over 11 billion CFU per capsule for vaginal flora balance, for women seeking vaginal flora support and recurrent candidiasis management.
• Apaisac Lip Balm Lip care product with squalane 18% and panthenol that nourishes, repairs, and rapidly soothes dry, chapped, and damaged lips, for consumers with sensitive or damaged lips.
• Apaisac Anti-Redness Soothing Cream Moisturizing cream that soothes and reduces redness for skin prone to redness, for consumers with rosacea, couperose, or redness-prone sensitive skin.
• Prescription and OTC Dermatology Medicines Portfolio Portfolio of prescription and OTC dermatology medicines (Efficort, Suniderma, Ionil T, Tineafin, Imacort, Imazol, Imaduo, Flucazol, Itrazol, Valaciclovir Therica) covering atopic dermatitis, psoriasis, mycosis, acne, and dermatological inflammation, distributed via pharmacies and through licensing partners.

Quantifiable outcome

• Hair loss reduced with CYSTIPHANE Anti Hair Loss Lotion - clinically proven efficacy on 20 subjects after 45 and 90 days
• +2 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• GaldermacoreStrategic or Co-development Partner · 1 January 2017Major acquisition in 2017 strengthening Laboratoires Bailleul's position in Dermatology. Acquired assets including Efficort, Suniderma, Ionil T, Tineafin, Imacort, Imazol, Imaduo, Flucazol, Itrazol, Valaciclovir Therica, involving over 35 countries and 100+ marketing authorizations. Goal was to bolster portfolio and core expertise in atopic dermatitis, psoriasis, and mycosis treatment.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Pierre Fabre: French family-owned pharmaceutical and dermo-cosmetic group with strong dermatology franchise including Ducray (hair care) and Avène (sensitive skin). Comparable as mid-size European player with similar pharmacy distribution model and family-ownership profile.
• NAOS (Bioderma, Institut Esthederm): French independent dermo-cosmetic group with Bioderma leading pharmacy-channel dermatology brand. Comparable as independent European dermo-cosmetic specialist with pharmacy distribution, sensitive skin focus, and similar family-owned heritage.
• Uriage (Puig): French thermal water-based dermo-cosmetic brand owned by Puig. Comparable as pharmacy-channel dermatology brand addressing sensitive skin, baby care, and intimate hygiene, overlapping with Bailleul's APAISAC and FEMILYANE ranges.
• Ducray (Pierre Fabre): Hair care brand under Pierre Fabre specializing in hair loss, dandruff, and scalp conditions. Closely comparable to Bailleul's CYSTIPHANE franchise with overlapping therapeutic focus on hair loss treatments and pharmacy distribution.
• ACM Noviderm: European dermo-cosmetic laboratory specializing in dermatological skincare sold through pharmacy channels. Comparable as independent mid-size dermo-cosmetic player with similar product categories (acne, sensitive skin, hair care) and pharmacy distribution model.

Broad incumbents

• Galderma: Global dermatology pure-play and former Nestlé-owned specialty pharma. Comparable as dermatology Rx/OTC leader and the seller of assets Bailleul acquired in 2017, providing direct overlap in atopic dermatitis, psoriasis, and mycosis treatment areas.
• La Roche-Posay (L'Oréal): L'Oréal-owned dermo-cosmetic brand focused on sensitive skin, dermatology, and pharmacy distribution. Comparable as direct channel competitor in pharmacy-dermo-cosmetic segment, though supported by L'Oréal's substantially larger R&D and marketing budgets.
• Vichy (L'Oréal): L'Oréal-owned pharmacy-distributed dermo-cosmetic brand focused on sensitive skin and hair/scalp health. Comparable channel strategy (pharmacy distribution) and adjacent product categories (sensitive skin, hair care), though backed by significantly larger corporate parent.

Emerging players

• Phyto (Laboratoire Native): French botanical-based hair care brand addressing hair loss and scalp conditions. Comparable therapeutic area (hair loss, scalp health) with plant-based formulation philosophy similar to Bailleul's cystine approach, though positioned more as consumer beauty than pharmacy dermo-cosmetic.

Regional players

• ISDIN: Spanish dermatology pharmaceutical company with strong Latin American presence. Comparable as independent mid-size dermatology pharma with dermatology Rx, OTC, and dermo-cosmetic portfolio, providing a peer for international expansion benchmarking, particularly into Mediterranean and Latin American markets.

Market position

Weaknesses1 record

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratoires Bailleul